TY - JOUR
T1 - Preoperative Neurological Changes on Outcomes in Large-Vessel Occlusion Due to Intracranial Atherosclerotic Disease
AU - Yoshimoto, Takeshi
AU - Tanaka, Kanta
AU - Koge, Junpei
AU - Uchida, Kazutaka
AU - Imamura, Hirotoshi
AU - Toyoda, Kazunori
AU - Yamagami, Hiroshi
AU - Sakai, Nobuyuki
AU - Shirakawa, Manabu
AU - Beppu, Mikiya
AU - Matsumaru, Yuji
AU - Matsumoto, Yasushi
AU - Todo, Kenichi
AU - Hayakawa, Mikito
AU - Shindo, Seigo
AU - Morimoto, Masafumi
AU - Takeuchi, Masataka
AU - Ikeda, Hiroyuki
AU - Ishihara, Hideyuki
AU - Kakita, Hiroto
AU - Sano, Takanori
AU - Araki, Hayato
AU - Nomura, Tatsufumi
AU - Sakakibara, Fumihiro
AU - Yoshimura, Shinichi
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/9/1
Y1 - 2025/9/1
N2 - BACKGROUND AND OBJECTIVES: We aimed to clarify the association between neurological deterioration preendovascular therapy (EVT) and outcome in patients with large-vessel occlusion due to intracranial atherosclerotic disease (ICAD-LVO) undergoing EVT. METHODS: Consecutive patients with acute ischemic stroke due to ICAD-LVO within 24 h of onset who underwent EVT were enrolled in the Japanese multicenter registry from 2017 to 2019. Patients were grouped according to neurological severity transition as follows: mild symptoms (baseline National Institutes of Health Stroke Scale [NIHSS] score <6 and NIHSS score pre-EVT <6), symptom deterioration (baseline NIHSS score <6 and NIHSS score pre-EVT ≥6), and severe symptoms (baseline NIHSS score ≥6 and NIHSS score pre-EVT ≥6). Outcomes included favorable outcomes (modified Rankin Scale [mRS] score of 0-2 at 90 days), ordinal mRS shift, and symptomatic intracranial hemorrhage. Multivariable logistic regression assessed the association of outcomes with the transition of neurological severity by calculating odds ratios and 95% CIs, with mild symptoms as reference. RESULTS: In total, 480 patients with acute ICAD-LVO who underwent EVT (150 women [31.2%]; median age, 72 years IQR, 66-80) and had median baseline NIHSS score 12 (IQR, 6-20) were analyzed. Patients with symptom deterioration (n = 34) and severe symptoms (n = 375) had lower favorable outcomes (deterioration 38.2% vs mild 62.9%; adjusted odds ratio 0.30, 95% CI 0.09-0.97, severe 35.3%; 0.47, 0.33-0.65) and a significant mRS shift (deterioration vs mild; 3.63, 1.46-9.03, severe; 2.27, 1.74-2.96) than those with mild symptoms (n = 71). Symptomatic intracranial hemorrhage rates did not differ (mild 0%; deterioration 0%; severe 1.9%). CONCLUSION: Patients with ICAD-LVO who experienced worsening symptoms were less likely to achieve favorable outcomes after EVT than those with mild symptoms. Early identification of neurological deterioration and EVT intervention may improve outcomes in these patients.
AB - BACKGROUND AND OBJECTIVES: We aimed to clarify the association between neurological deterioration preendovascular therapy (EVT) and outcome in patients with large-vessel occlusion due to intracranial atherosclerotic disease (ICAD-LVO) undergoing EVT. METHODS: Consecutive patients with acute ischemic stroke due to ICAD-LVO within 24 h of onset who underwent EVT were enrolled in the Japanese multicenter registry from 2017 to 2019. Patients were grouped according to neurological severity transition as follows: mild symptoms (baseline National Institutes of Health Stroke Scale [NIHSS] score <6 and NIHSS score pre-EVT <6), symptom deterioration (baseline NIHSS score <6 and NIHSS score pre-EVT ≥6), and severe symptoms (baseline NIHSS score ≥6 and NIHSS score pre-EVT ≥6). Outcomes included favorable outcomes (modified Rankin Scale [mRS] score of 0-2 at 90 days), ordinal mRS shift, and symptomatic intracranial hemorrhage. Multivariable logistic regression assessed the association of outcomes with the transition of neurological severity by calculating odds ratios and 95% CIs, with mild symptoms as reference. RESULTS: In total, 480 patients with acute ICAD-LVO who underwent EVT (150 women [31.2%]; median age, 72 years IQR, 66-80) and had median baseline NIHSS score 12 (IQR, 6-20) were analyzed. Patients with symptom deterioration (n = 34) and severe symptoms (n = 375) had lower favorable outcomes (deterioration 38.2% vs mild 62.9%; adjusted odds ratio 0.30, 95% CI 0.09-0.97, severe 35.3%; 0.47, 0.33-0.65) and a significant mRS shift (deterioration vs mild; 3.63, 1.46-9.03, severe; 2.27, 1.74-2.96) than those with mild symptoms (n = 71). Symptomatic intracranial hemorrhage rates did not differ (mild 0%; deterioration 0%; severe 1.9%). CONCLUSION: Patients with ICAD-LVO who experienced worsening symptoms were less likely to achieve favorable outcomes after EVT than those with mild symptoms. Early identification of neurological deterioration and EVT intervention may improve outcomes in these patients.
KW - Endovascular therapy
KW - Intracranial atherosclerotic disease
KW - Neurological deterioration
KW - Stroke
UR - https://www.scopus.com/pages/publications/105013842446
UR - https://www.scopus.com/pages/publications/105013842446#tab=citedBy
U2 - 10.1227/neuprac.0000000000000156
DO - 10.1227/neuprac.0000000000000156
M3 - Article
AN - SCOPUS:105013842446
SN - 2834-4383
VL - 6
JO - Neurosurgery Practice
JF - Neurosurgery Practice
IS - 3
M1 - e000156
ER -